Home
Live Updates
Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars : vimarsana.com
Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
While rare diseases impact a small population, the cost to society is staggering. It may be in the range of $7.2-$8.6 trillion per year.
Related Keywords
Peter Marks ,
Disease Grant Program ,
Pilot Program ,
Rare Pediatric Disease Priority Review Voucher Program ,
Rare Disease Drug Developers ,
Orphan Drug Tax Credit ,
Biologics Evaluation ,
Drug Evaluation ,
Accelerating Rare ,
Empower Rare Disease Drug Developers ,
Rare Disease Endpoint Advancement ,
Critical Path ,
Rare Neurodegenerative Diseases ,
Rare Diseases ,
Ealth Care ,
Health Care Cost ,
Ealth Care Cost Us ,
Ealth Care Cost To Society ,
Best Health Care System ,
Are Disease Insurance ,
Edicine ,
Ealth Care Industry ,
Harma ,
Harmaceutical Industry ,
vimarsana.com © 2020. All Rights Reserved.